Suven Life Sciences announced that the 35th Annual General Meeting(AGM) of the company will be held on 2 August 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 26.54 crore in the quarter ended March 2024 as against net loss of Rs 27.64 crore during the previous quarter ended March 2023. Sales declined 8.43% to Rs 2.39 crore in the quarter ended March 2024 as against Rs 2.61 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 105.08 crore in the year ended March 2024 as against net loss of Rs 118.27 crore during the previous year ended March 2023. Sales declined 13.66% to Rs 11.69 crore in the year ended March 2024 as against Rs 13.54 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2.392.61 -8 11.6913.54 -14 OPM %-1266.95-1207.66 --1095.04-929.76 - PBDT-26.03-25.97 0 -107.04-117.72 9 PBT-27.54-27.64 0 -113.54-124.27 9 NP-26.54-27.64 4 -105.08-118.27 11 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 6 May 2024.Powered by Capital Market - Live News

Net Loss of Suven Life Sciences reported to Rs 41.76 crore in the quarter ended December 2023 as against net loss of Rs 51.12 crore during the previous quarter ended December 2022. Sales declined 18.33% to Rs 2.45 crore in the quarter ended December 2023 as against Rs 3.00 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales2.453.00 -18 OPM %-1885.71-1719.33 - PBDT-40.16-49.44 19 PBT-41.76-51.12 18 NP-41.76-51.12 18 Powered by Capital Market - Live News

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 30 January 2024.Powered by Capital Market - Live News